Report Overview
Neglected tropical diseases(NTDs) are a diverse group oftropical infectionswhich are common in low-income populations indeveloping regionsofAfrica,Asia, and theAmericas. They are caused by a variety of pathogens such asviruses,bacteria,protozoaandhelminths.
This report provides a deep insight into the global Neglected Tropical Diseases Drugs and Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neglected Tropical Diseases Drugs and Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neglected Tropical Diseases Drugs and Vaccine market in any manner.
Global Neglected Tropical Diseases Drugs and Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Artecef BV
- GlaxoSmithKline
- AstraZeneca
- Novartis
- Sanofi-Aventis
- Ranbaxy Labs
- Lupin
- Macleods Pharmaceuticals
- Cipla
- Romark Laboratories
- Toyama Chemica
Market Segmentation (by Type)
- Malaria
- Ebola
- Dengue
- Chagas
- Leishmaniasis
- Other
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neglected Tropical Diseases Drugs and Vaccine Market
Overview of the regional outlook of the Neglected Tropical Diseases Drugs and Vaccine Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neglected Tropical Diseases Drugs and Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neglected Tropical Diseases Drugs and Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Landscape
3.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neglected Tropical Diseases Drugs and Vaccine Sales Sites, Area Served, Product Type
3.6 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.6.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neglected Tropical Diseases Drugs and Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2019-2024)
7 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2019-2024)
7.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2024)
8 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Region
8.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Artecef BV
9.1.1 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.1.4 Artecef BV Business Overview
9.1.5 Artecef BV Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
9.1.6 Artecef BV Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Novartis
9.4.1 Novartis Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Sanofi-Aventis
9.5.1 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.5.4 Sanofi-Aventis Business Overview
9.5.5 Sanofi-Aventis Recent Developments
9.6 Ranbaxy Labs
9.6.1 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.6.4 Ranbaxy Labs Business Overview
9.6.5 Ranbaxy Labs Recent Developments
9.7 Lupin
9.7.1 Lupin Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.7.4 Lupin Business Overview
9.7.5 Lupin Recent Developments
9.8 Macleods Pharmaceuticals
9.8.1 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.8.4 Macleods Pharmaceuticals Business Overview
9.8.5 Macleods Pharmaceuticals Recent Developments
9.9 Cipla
9.9.1 Cipla Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.9.4 Cipla Business Overview
9.9.5 Cipla Recent Developments
9.10 Romark Laboratories
9.10.1 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.10.4 Romark Laboratories Business Overview
9.10.5 Romark Laboratories Recent Developments
9.11 Toyama Chemica
9.11.1 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.11.4 Toyama Chemica Business Overview
9.11.5 Toyama Chemica Recent Developments
10 Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
10.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast
10.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region
10.2.4 South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neglected Tropical Diseases Drugs and Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Type (2025-2030)
11.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neglected Tropical Diseases Drugs and Vaccine by Type (2025-2030)
11.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2022)
Table 10. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Sales Sites and Area Served
Table 12. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neglected Tropical Diseases Drugs and Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 22. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Type (Kilotons)
Table 23. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 24. Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) by Application
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2019-2024)
Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 44. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 45. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Artecef BV Business Overview
Table 47. Artecef BV Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
Table 48. Artecef BV Recent Developments
Table 49. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 50. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 51. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 56. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 57. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Novartis Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 62. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 63. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis Business Overview
Table 65. Novartis Recent Developments
Table 66. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 67. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 68. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sanofi-Aventis Business Overview
Table 70. Sanofi-Aventis Recent Developments
Table 71. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 72. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 73. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Ranbaxy Labs Business Overview
Table 75. Ranbaxy Labs Recent Developments
Table 76. Lupin Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 77. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 78. Lupin Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Lupin Business Overview
Table 80. Lupin Recent Developments
Table 81. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 82. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 83. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Macleods Pharmaceuticals Business Overview
Table 85. Macleods Pharmaceuticals Recent Developments
Table 86. Cipla Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 87. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 88. Cipla Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Cipla Business Overview
Table 90. Cipla Recent Developments
Table 91. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 92. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 93. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Romark Laboratories Business Overview
Table 95. Romark Laboratories Recent Developments
Table 96. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 97. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 98. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Toyama Chemica Business Overview
Table 100. Toyama Chemica Recent Developments
Table 101. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Neglected Tropical Diseases Drugs and Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Neglected Tropical Diseases Drugs and Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (M USD)
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type
Figure 18. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2023
Figure 20. Market Size Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application
Figure 24. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application in 2023
Figure 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2019-2024)
Figure 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2023
Figure 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2023
Figure 44. China Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Application (2025-2030)
